Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-825 in Atrial Fibrillation
NCT03950843Phase 3Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Apr 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carvedilol in Atrial fibrillation (AFib), sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
carvedilol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03950843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03950843.